Rapport Therapeutics, Inc. Common Stock (RAPP NASDAQ) stock market data APIs

$13.77 1.08(8.5%)
as of January 14, 2025

Rapport Therapeutics, Inc. Common Stock Financial Data Overview

Price chart is built with Anychart

Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.

Prev. Close 12.69
Open 13.77
Volume 101 K
High 14.67
Low 12.095
52 wk Range 12.095-29.74
Market Cap 762 M
Shares Outstanding 36 577 K
Revenue 0
EPS -0.4795

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Rapport Therapeutics, Inc. Common Stock data using free add-ons & libraries


Get Rapport Therapeutics, Inc. Common Stock Fundamental Data

Rapport Therapeutics, Inc. Common Stock Fundamental data includes:

  • Net Revenue: 0
  • EBITDA: -61 816 000
  • Earnings Per Share: -1
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Rapport Therapeutics, Inc. Common Stock Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2024-11-07
  • EPS/Forecast: NaN
GET THE PACKAGE

Get Rapport Therapeutics, Inc. Common Stock End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Rapport Therapeutics, Inc. Common Stock News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat